What's new in the world of diabetes?

Rochester, NY US
November 13, 2019

This CE activity will review current guidelines for the management of patients with diabetes and comorbidities such as renal and cardiovascular diseases. A detailed review of recently published literature that discusses newly approve diabetes medications as well as updates for previously approved medications. This CE will provide pharmacists in attendance with current information about diabetes medications and considerations for use safe and effective use in specific patient populations. After participating in this CE pharmacists should have a greater understanding of new trial data and how to apply the information into practice.

Target Audience


Learning Objectives

Learning objectives

  1. Summarize 2019 guideline-based recommendations for patients with Type 2 diabetes and comorbidities associated with renal and cardiovascular disease
  2. Evaluate new clinical trial data supporting the approval of oral semaglutide to describe its role in therapy
  3. Analyze the cardiovascular benefit of dulaglutide based on new clinical trial data
  4. Interpret clinical data to support new indication for canagliflozin with renal disease benefits
  5. Design patient-specific medication regimens and monitoring plans for Type 2 diabetes patients with cardiovascular disease, renal disease, or a combination of both

Additional Information

Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 General CEU – Attendance
Course opens: 
Course expires: 
Event starts: 
11/13/2019 - 12:00pm CST
Event ends: 
11/13/2019 - 1:00pm CST
University of Rochester Medical Center
601 Elmwood Ave.
Rochester, NY 14642
United States
Relevant financial relationships: Planning committee members and presenters have nothing to disclose
Planning committee members
Samantha Listman, PHarmD
Ambulatory Care Clinical Pharmacy Specialist
University of Rochester Medical Center
Kristin Reindel, PharmD
PGY1 Community Resident
University of Rochester Medical Center
Course reviewer
Katrina Harper, PharmD, MBA, BCPS, DPLA
Clinical Pharmacy Director
Kristin Reindel, PharmD
PGY1 Community Resident
University of Rochester Medical Center
Joint Accreditation Statement:
In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Designation Statements:
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-9999-19-222-L01-P
Universal Activity Number: JA0006103-9999-19-222-L01-T
Vizient, Inc. will award CEUs to each participant who successfully completes this program. The CEU is a nationally recognized unit of measure for continuing education and training programs that meet certain criteria (1 contact hour = 0.1 CEU).

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 General CEU – Attendance


Please login or register to take this course.